MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/circulationaha.126.079823

Медицинская библиотека · Circulation · 2026

SREBP1 Transactivation of NHE3 Impairs Cardiac Contraction and Aggravates Heart Failure.

Gu Huijun, Wen Jianpei, Liu Yiyi, Xue Yanbo, Zhao Mingming, Zhao Yifei, Bi Lantian, Cui Hongtu, Zhang Wenming, Xu Wenli, Wang Kang, Deng Yawen, Yu Xiaoyue, Wang Haifan, Hu Jingui, Liu Wei, Guo Yuxuan, Chen Chen, Dong Erdan, Zhang Youyi, Shyy John Y-J, Xiao Han

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Heart failure with reduced ejection fraction (HFrEF) is characterized by impaired contractility and high mortality. Dysregulation of intracellular ion (ie, Na+/H+ and Ca2+) cycling underlies reduced cardiac contractility. The mechanisms linking myocardial stress to this ion dysregulation remain incompletely understood. Although the metabolic transcription factor SREBP1 (sterol regulatory element-binding protein 1) remodels cardiac metabolism, its role in HFrEF without metabolic comorbidities, particularly regarding ion handling, remains undefined.

METHODS

Cardiac tissues from HFrEF patients and mice subjected to transverse aortic constriction (TAC) were analyzed for SREBP1 transactivation of sodium-hydrogen exchanger 3 (NHE3). Cardiomyocyte-specific SREBP1 transgenic (Srebp1a-Tg) and knockdown (Cre-Srebf1f/f) mice were generated. AAV9 vectors carrying Slc9a3 (encoding NHE3), Srebp1a or shRNA against Slc9a3, driven by the cardiomyocyte-specific cTnT promoter, were used to validate the role of the SREBP1-NHE3 in HFrEF.

RESULTS

SREBP1 was activated in human hearts with HFrEF because of dilated cardiomyopathy, but without diabetes or hyperlipidemia, and in TAC-induced HFrEF mouse hearts. Srebp1a-Tg mice exhibited impaired cardiac contractility with dysregulated calcium handling in cardiomyocytes without apparent lipid accumulation. Transcriptomics analysis identified increased NHE3 expression in Srebp1a-Tg mice, confirmed by NHE3 upregulation in TAC hearts and human failing hearts. ChIP-seq, ChIP, and promoter reporter assay demonstrated direct transcriptional regulation of SLC9A3 (encoding NHE3) by SREBP1. NHE3 activity was enhanced in cardiomyocytes isolated from Srebp1a-Tg mice or those underwent TAC, whereas cardiomyocyte-specific Srebf1 knockdown in TAC mice reduced NHE3 activity. Cardiomyocyte-specific knockdown of Srebf1 or Slc9a3 restored calcium handling and improved cardiac function in TAC mice. In Srebp1a-Tg mice, NHE3 knockdown alleviated Na+ and Ca2+ overload and rescued cardiac systolic dysfunction. Conversely, NHE3 overexpression caused contractile impairment in both Cre-Srebf1f/f mice and controls, which offset the protective effect because of SREBP1 loss in the context of Na+ and Ca2+ overload.

CONCLUSIONS

SREBP1 directly transactivates cardiac NHE3 during the progression of HFrEF, leading to dysregulated calcium handling and impaired contractility, revealing a novel, noncanonical role for SREBP1 in the pathophysiology of heart failure and offering a potential new therapeutic target.

Для цитирования: Gu Huijun, Wen Jianpei, Liu Yiyi, Xue Yanbo, Zhao Mingming, Zhao Yifei, Bi Lantian, Cui Hongtu, Zhang Wenming, Xu Wenli, Wang Kang, Deng Yawen, Yu Xiaoyue, Wang Haifan, Hu Jingui, Liu Wei, Guo Yuxuan, Chen Chen, Dong Erdan, Zhang Youyi, Shyy John Y-J, Xiao Han. SREBP1 Transactivation of NHE3 Impairs Cardiac Contraction and Aggravates Heart Failure.. Circulation. 2026. DOI: 10.1161/circulationaha.126.079823.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.